Hospital Público da Mariña, Burela, Spain.
Hospital Universitario Clinico San Cecilio, Instituto de Investigacion Ibs.Granada, Granada, Spain.
Enferm Infecc Microbiol Clin (Engl Ed). 2024 Jan;42(1):13-16. doi: 10.1016/j.eimce.2022.12.007. Epub 2023 Jan 7.
Viral load is a very useful marker for monitoring patients infected with HBV and HCV. This work compares assays based on transcription-mediated amplification (TMA) and on real-time PCR (RT-PCR) to verify whether they can be interchangeable.
A bicentric study, in which 147 plasma samples from patients infected with HBV and 229 with HCV were analyzed, was carried out. TMA-based assays (Aptima® HBV Quant and Aptima® HCV Quant Dx, employing Panther system (Hologic®)) and RT-PCR (COBAS® AmpliPrep/COBAS® TaqMan® and COBAS® 6800) were used and the degree of concordance between them was calculated.
Viral load was detected in both systems in 60 (40.82%) HBV samples (median log viral load: COBAS: 2.51IU/mL (IQR 2.20-3.17), Panther: 2.71IU/mL (IQR 2.21-3.22)) and in 39 (16.96%) HCV samples (median log viral load: COBAS: 3.93IU/mL (IQR 2.24-6.01), Panther: 3.80IU/mL (IQR 1.99-6.14)). The agreement between both systems was κ=0.943 for HBV and κ=0.925 for HCV. Comparison of viral load samples detected by both assays showed a hight correlation for HBV (R=0.86) and for HCV (R=0.97).
Both TMA and RT-PCR based assays may be interchangeable for the management of patients infected with HBV and HCV.
病毒载量是监测乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染者的非常有用的标志物。本研究比较了基于转录介导扩增(TMA)和实时 PCR(RT-PCR)的检测方法,以验证它们是否可以互换。
进行了一项两中心研究,分析了 147 例 HBV 感染患者和 229 例 HCV 感染患者的血浆样本。采用 TMA 检测法(Aptima®HBV Quant 和 Aptima®HCV Quant Dx,采用 Panther 系统(Hologic®))和 RT-PCR(COBAS®AmpliPrep/COBAS®TaqMan®和 COBAS®6800),并计算了它们之间的一致性程度。
两种系统均检测到 60 例(40.82%)HBV 样本中的病毒载量(COBAS 中位数对数病毒载量:2.51IU/mL(IQR 2.20-3.17), Panther:2.71IU/mL(IQR 2.21-3.22))和 39 例(16.96%)HCV 样本中的病毒载量(COBAS 中位数对数病毒载量:3.93IU/mL(IQR 2.24-6.01), Panther:3.80IU/mL(IQR 1.99-6.14))。两种系统之间的一致性为 HBV 的 κ=0.943 和 HCV 的 κ=0.925。对两种检测方法检测到的病毒载量样本进行比较,发现 HBV 相关性高(R=0.86),HCV 相关性高(R=0.97)。
基于 TMA 和 RT-PCR 的检测方法可互换用于管理 HBV 和 HCV 感染者。